Back
Gitlab, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
21
GTLB
Gitlab, Inc.
Last Price:
$39.06
Seasonality Move:
4.37%
Sell
39
CRSP
CRISPR Therapeutics AG
Last Price:
$57.37
Seasonality Move:
11.08%
Sell
21
Gitlab, Inc. (GTLB)
is a Sell
Is Gitlab, Inc. a Buy, Sell or Hold?
-
The current Gitlab, Inc. [GTLB] share price is $39.07. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $57.36. The Score for CRSP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GTLB Stock Price Chart
What is Gitlab, Inc.'s stock price today?
-
The Gitlab, Inc. share price today is $39.07Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $57.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
GTLB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.03 | Sell |
| Relative Strength Index (14 RSI): | 38.83 | Sell |
| Chaikin Money Flow: | 625552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.83 - 46.31) | Sell |
| Bollinger Bands (100): | (42.34 - 48.6) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 53.03 | Buy |
| Chaikin Money Flow: | -452263 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.33 - 57.11) | Buy |
| Bollinger Bands (100): | (52.98 - 66.24) | Sell |
GTLB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.74 | Sell |
| 20-day SMA: | 42.12 | Sell |
| 50-day SMA: | 44.94 | Sell |
| 200-day SMA: | 46.67 | Sell |
| 8-day EMA: | 39.55 | Sell |
| 20-day EMA: | 41.65 | Sell |
| 50-day EMA: | 43.98 | Sell |
| 200-day EMA: | 47.44 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.87 | Buy |
| 20-day SMA: | 53.42 | Buy |
| 50-day SMA: | 61.37 | Sell |
| 200-day SMA: | 50.58 | Buy |
| 8-day EMA: | 55.42 | Buy |
| 20-day EMA: | 55.31 | Buy |
| 50-day EMA: | 56.41 | Buy |
| 200-day EMA: | 35.79 | Buy |
Gitlab, Inc. Earnings Growth & GTLB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Gitlab, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||